Filing Details

Accession Number:
0000950170-24-116780
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-10-23 19:43:35
Reporting Period:
2024-10-21
Accepted Time:
2024-10-23 19:43:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1750149 Inhibikase Therapeutics Inc. IKT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1612551 Amit Munshi 3350 Riverwood Parkway Se, Suite 1900
Atlanta GA 30339
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-10-21 365,000 $1.37 365,000 No 4 P Indirect By Amit Munshi Revocable Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Amit Munshi Revocable Trust
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Acquisiton 2024-10-21 60,000 $0.00 60,000 $2.22
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
60,000 2034-10-21 No 4 A Direct
Footnotes
  1. The option shares vest 50% on each of the first two anniversaries of October 21, 2024.